-
GLP-1 medicine improves liver health independent of weight loss, study finds
Researchers at Toronto's Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that mimic the gut... Read more -
Scientists make Parkinson's drug from plastic in world first
It's easy to see discarded plastic as nothing more than waste. Much of it ends up in landfill, breaking down... Read more -
New drug doubles 1-year survival in pancreatic cancer trial
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than... Read more -
Students publish paper validating optimal caffeine dosage for newborns with heart disease
Montana State University students published a paper alongside Duke University researchers in the Journal of Pediatric Pharmacology and Therapeutics this... Read more -
Pain-sensing neurons mapped in unprecedented detail, pointing to new chronic pain drug targets
One in five people worldwide suffers from chronic inflammatory pain. Meanwhile, about two thirds of those affected find little relief... Read more -
Researchers demonstrate drug's effectiveness in drawing out dormant HIV from immune cells
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy,... Read more -
Environmental enrichment lowered stress hormones tied to fentanyl relapse in rats
Combating the opioid crisis relies on identifying new prevention strategies for problematic fentanyl use. In a collaboration between Washington State... Read more -
As RSV evolves, a two‑pronged antibody cocktail aims to stay ahead
Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented... Read more -
New drug combination doubles down on Alzheimer's treatments
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found... Read more -
Experimental drug cuts Parkinson's-linked protein up to 60% in early trial
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human... Read more -
Coffee's sweet spot may help mental health in the long run
Your morning cup of coffee may be more than just a pick-me-up. It may also be a simple boost for... Read more -
Injectable peptides are the new anti‑aging trend. But what evidence do we have they're safe for humans?
Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media as tools... Read more -
AI scans 400,000 Reddit posts to flag overlooked GLP-1 side effects
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the... Read more -
Why autism affects more men than women—MDGA1 gene mutation may help explain
Researchers have discovered that a mutation of the MDGA1 gene, a key factor modulating the connections and characteristics between nerve... Read more -
How the blood-brain barrier opens: Two proteins may guide future drug delivery
The cells that line the blood vessels in our brains are highly selective. By deciding which molecules are allowed in... Read more
